The efficacy and safety of pyrotinib in treating HER2‐positive breast cancer patients with brain metastasis: A multicenter study

PURPOSE: To investigate the efficacy and safety of pyrotinib in treating patients with human epidermal growth factor receptor type 2 (HER2)‐positive breast cancers with brain metastasis. PATIENTS AND METHODS: This is a multicenter retrospective study, and the HER2‐positive breast cancer patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Min, Fu, Chao, Li, Shanshan, Chen, Fang, Yang, Yongteng, Wang, Chunjian, Qin, Jie, Liu, Shuaishuai, Zhang, Ranran, Wang, Changyuan, Zong, Jinbao, Meng, liping, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817079/
https://www.ncbi.nlm.nih.gov/pubmed/34962098
http://dx.doi.org/10.1002/cam4.4481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817079/
https://www.ncbi.nlm.nih.gov/pubmed/34962098
http://dx.doi.org/10.1002/cam4.4481

Ejemplares similares